News

Published on 30 Jan 2023 on Insider Monkey via Yahoo Finance

15 Biggest Neuroscience Companies in the World


Article preview image

In this article, we will discuss the 15 Biggest Neuroscience Companies in the World. You can skip our industry overview and go directly to the 5 Biggest Neuroscience Companies in the World.

As the name suggests, neuroscience concerns itself with the development, structure, and functions of the nervous system, intending to enhance neurological health. According to the World Health Organization, one out of every three persons will suffer from a neurological disorder at some point in their lives, making these disorders the leading cause of disability and the second leading cause of death, accounting for approximately 9 million deaths each year.

At the same time, WHO recognizes that in most countries, the "treatment gap" for these disorders is "unacceptably high." This implies a massive opportunity for neuroscience companies. As per IMARC, the global neuroscience market was valued at $32.22 billion in 2021 and is expected to rise to $41.24 billion by 2027 at a CAGR of 3.80%.

NYSE.TAK price evolution
NYSE.NVS price evolution
NASDAQ.NBIX price evolution
NASDAQ.BIIB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Neurocrine Biosciences upgraded at Wells Fargo on pipeline

Wells Fargo upgrades Neurocrine BioSciences citing its strong pipeline. Read more here.

Seeking Alpha 24 Apr 2024

Neurocrine reports promising phase 2 depression drug data By Investing.com

Neurocrine (NASDAQ:NBIX) Biosciences, Inc. (NASDAQ:NBIX) announced today that its Phase 2 study f...

Investing.com 23 Apr 2024

Neurocrine stock gains on depression trial win (NASDAQ:NBIX)

Neurocrine Biosciences (NBIX) stock rises as its Phase 2 trial for depression therapy NBI-1065845...

Seeking Alpha 23 Apr 2024

Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive...

Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive...

Investing.com 23 Apr 2024

10 Best Performing Biotech ETFs in 2024

In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our ...

Insider Monkey via Yahoo Finance 22 Apr 2024

Neurocrine Biosciences exec sells over $2.6m in stock By Investing.com

Neurocrine (NASDAQ:NBIX) Biosciences Inc.'s (NASDAQ:NBIX) Chief Commercial Officer, Eric Benevich...

Investing.com 17 Apr 2024

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its...

H.C. Wainwright initiated coverage on Voyager Therapeutics Inc VYGR, noting a growing franchise o...

Benzinga 19 Mar 2024

Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells 3,000 Shares

Neurocrine Biosciences Inc (NASDAQ:NBIX), a company specializing in the development of treatments...

GuruFocus.com via Yahoo Finance 16 Mar 2024

Neurocrine Biosciences exec sells shares worth over $420k By Investing.com

In a recent financial move, Ingrid Delaet, the Chief Regulatory Officer of Neurocrine (NASDAQ:NBI...

Investing.com 15 Mar 2024

Neurocrine Biosciences director pops Richard F sells $3.26M in stock By Investing.com

In a recent transaction, Pops Richard F, a director at Neurocrine (NASDAQ:NBIX) Biosciences Inc...

Investing.com 15 Mar 2024